Read the history in context
Records, not a safety rating.
Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.
View source coverage →Severity Breakdown
Class I — Serious
0Class II — Moderate
1Class III — Low Risk
0Categories
MEDICATION
Recall Timeline
Class IIFDASep 23, 2026
J&J INNOVATIVE MEDICINE — Presence of particulate matter.
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01 Presence of particulate matter.
Track J&J INNOVATIVE MEDICINE recalls automatically
Get an alert when a matching J&J INNOVATIVE MEDICINE recall turns up.
Start Free Trial